"Don't use copper peptides with vitamin C" is one of the most repeated rules in skincare, and it does not come from a study. We went looking for the one it might come from. On 2026-09-06 we searched PubMed for every pairing of a copper peptide with the ingredients it is supposedly incompatible with, read what came back, and compared it against what the two best-known copper peptide brands tell their own customers. The literature is two papers, both from laboratories rather than faces, and the brands contradict each other.
The search, and what it returned
| Pairing searched (PubMed, 2026-09-06) | Records |
|---|---|
| Copper tripeptide / GHK-Cu and vitamin C or ascorbic acid | 1 |
| Copper tripeptide / GHK-Cu and retinoids, retinol or tretinoin | 1 |
| Copper tripeptide / GHK-Cu and niacinamide | 0 |
| Copper tripeptide / GHK-Cu and glycolic, salicylic or alpha-hydroxy acids | 0 |
| Randomized trials of skincare layering, application order or compatibility (any ingredient) | 4 |
Four randomized trials exist on the whole question of what order to apply skincare in, for any ingredient, and none of them concerns copper peptides. The rules that fill comment sections and brand FAQs are drawn from something else.
The one vitamin C paper is from 1983 and it is not about skin
The single record joining a copper peptide with ascorbate is a biochemistry paper from forty-three years ago. L-ascorbic acid combined with either copper(II) ion or a copper(II)-tripeptide complex "extensively cleaved several viral DNAs and proteins under in vitro conditions", while neither ascorbate nor the copper tripeptide alone caused any apparent change. Adding catalase partially inhibited the DNA scission, which pointed to hydrogen peroxide, and the authors proposed the hydroxyl radical as a product (Chiou, J Biochem 1983).
Three details matter before anyone carries that into a bathroom cabinet. The substrate was viral DNA and purified protein in a tube, not skin. The copper peptide was copper diglycyl-L-histidine, which is not GHK-Cu — glycyl-L-histidyl-L-lysine is a different tripeptide. And the experiment was designed to demonstrate a damage mechanism, in conditions chosen to produce one.
The chemistry that is genuinely established
The underlying reaction is real and now well quantified. A 2021 study synthesized the literature, built a kinetics model and derived rate constants for ascorbate oxidation by transition metals, concluding that micromolar iron(III) and copper(II) are more important sinks for ascorbic acid than reactive oxygen species are. The copper reaction is catalytic rather than redox, with unit stoichiometry, producing hydrogen peroxide; the derived rate constants are 7.7 × 10⁴ M⁻² s⁻¹ for Cu(II) with ascorbic acid and 2.8 × 10⁶ M⁻² s⁻¹ with the ascorbate anion (Shen et al., Sci Rep 2021).
Catalytic matters: the copper is not consumed, so a small amount keeps degrading ascorbate. But every one of those measurements is for free copper ions in solution. The entire premise of a copper peptide is that the copper is held by the peptide — chelation is the mechanism the ingredient's own literature proposes for why GHK-Cu delivers copper without leaving it loose. Nobody has measured whether, or how fast, copper bound in GHK acts as a catalyst for ascorbate oxidation in a cosmetic formula. That is the gap, stated plainly, and it is the reason the rule is neither obviously right nor obviously wrong.
The one retinoid paper tested them side by side, not together
The single record joining copper peptides and retinoids is a Stanford study in a serum-free fibroblast model, using cell lines from patients' facial skin. Copper tripeptide at 1 × 10⁻⁹ mol/L, tretinoin at 1 × 10⁻⁵ mol/L, or vehicle was added at hour zero, and growth-factor secretion measured at 24, 72 and 120 hours. Tretinoin-treated normal fibroblasts secreted more basic fibroblast growth factor at 24 hours; keloid-producing fibroblasts treated with copper tripeptide secreted less TGF-β1 at 24 hours, with the same trend in normal cells (McCormack et al., Arch Facial Plast Surg 2001).
They were separate arms. The study asked what each does to a fibroblast, not what happens when both are on a face, and its authors' interest was scar formation rather than layering.
The brands do not agree, and both are selling copper
This is the part a reader can verify without a database. The Ordinary's copper peptide serum page advises against using it in the same routine as direct vitamin C, direct acids, retinoids or strong antioxidants. NIOD's page for its copper amino isolate serum lists no such restriction. Both products are copper peptide serums with disclosed concentrations, sold into the same market to the same readers.
When two sellers of the same ingredient publish opposite guidance, the guidance is not a reading of the evidence — there is not enough evidence to read two ways. It is a formulation judgement about a particular product, plus a house style about caution. Neither is dishonest; neither is a finding.
The better-supported reason for the same caution
There is a defensible argument for keeping copper peptides away from strong oxidizers, and it is not about your skin. GHK-Cu degrades fastest under oxidative conditions, so the risk being managed is to the ingredient in the bottle and in the film on the skin, not to the skin itself. That framing survives contact with the evidence; "vitamin C will make copper peptides damage your skin" does not, because the only experiment that showed damage used a different peptide on viral DNA in a tube.
Safety in cosmetic use has been assessed separately: the Cosmetic Ingredient Review panel concluded in 2014 that copper tripeptide-1 is safe in cosmetics as used, noting typical use concentrations then under 10 ppm, and in the one randomized GHK-Cu serum trial we could open, one participant of 40 had a minor reaction that resolved after stopping. Our copper peptides page carries that record in full.
What would settle it
A stability study measuring ascorbate and GHK-Cu concentrations over time in a realistic formula and on skin, or a split-face trial of the two applied together versus separately. Neither exists. Until one does, layering rules for this ingredient are formulation policy, and worth reading as such.
More on the ingredient itself: copper peptides for skin. The category-wide evidence count: peptides for skin and best peptides for skin. Our testing notes explain how this publication handles claims that outrun their evidence.
Sources
- PubMed searches run 2026-09-06 via NCBI E-utilities
esearch, title/abstract terms as described in the table. PubMed. - Chiou SH. DNA- and protein-scission activities of ascorbate in the presence of copper ion and a copper-peptide complex. J Biochem 1983;94(4):1259-67. PubMed 6654857.
- Shen J, Griffiths PT, Campbell SJ, Utinger B, Kalberer M, Paulson SE. Ascorbate oxidation by iron, copper and reactive oxygen species: review, model development, and derivation of key rate constants. Sci Rep 2021;11:7417. PubMed 33795736 · PMC8016884.
- McCormack MC, Nowak KC, Koch RJ. The effect of copper tripeptide and tretinoin on growth factor production in a serum-free fibroblast model. Arch Facial Plast Surg 2001;3(1):28-32. PubMed 11176716.
- Cosmetic Ingredient Review. Safety Assessment of Tripeptide-1, Hexapeptide-12, their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics. Final report, June 30, 2014. PDF.
- The Ordinary, Multi-Peptide + Copper Peptides 1% Serum; NIOD, Copper Amino Isolate Serum 3 1:1. Brand pages, accessed 2026-09-06.
Published by Peptide Glow Journal Editorial. No product is ranked, scored or affiliate-linked on this page.